According to a recent LinkedIn post from Acclaro Medical, the company is promoting an immersive educational event in Napa Valley focused on the future of skin rejuvenation. The post highlights that board-certified plastic surgeon Dr. Nima Naghshineh plans to discuss advanced techniques, real clinical outcomes, and the application of 2910 nm fiber laser technologies, including UltraClear and AuraLux, on June 5–6, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Acclaro Medical is using practitioner-focused education and live clinical content to deepen engagement with aesthetic medicine professionals and strengthen adoption of its laser platforms. For investors, this emphasis on training and thought-leader alignment may support higher utilization of installed systems, reinforce brand differentiation in the competitive aesthetics market, and potentially contribute to longer-term revenue growth from devices and recurring procedure usage.